Fig. 1From: Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case reportAxial (a) T2-weighted FLAIR MRI under stable clinical conditions, showing several supratentorial lesions; axial (b) T1-weighted images showing no lesions with ring gadolinium-enhancement, (c) sagittal T2-weighted FLAIR MRI showing two spinal cord lesionsBack to article page